Tong Ren Tang Group
PublicTong Ren Tang Group is now publicly traded
The data on this page reflects Tong Ren Tang Group's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 7, 2026
Last Round
Follow-on Offering
Sep 6, 2013
Est. Valuation at Exit
$1.9B
Total Funding Raised
$296.3M
Company Overview
Tong Ren Tang Group is a pharmaceutical company that manufactures and retails traditional Chinese medicine products and provides healthcare services.
AI Layer
Application
Keywords
Tong Ren Tang Group Comparables
Compare Tong Ren Tang Group with similar companies based on industry and business-model similarity.
No public comparables are available for Tong Ren Tang Group. Request access to learn about comparables coverage.
Request accessTong Ren Tang Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 7, 2026 | ||||
| Follow-on Offering | Sep 6, 2013 | ||||
| IPO | Oct 31, 2000 | ||||
| IPO | Jun 25, 1997 |
Tong Ren Tang Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITIC Construction Investment Securities Co., Ltd. | IPO |
| China International Capital Corporation | IPO |
| BOCI Asia Limited | IPO |
| Core Pacific-Yamaichi International (H.K.) Limited | IPO |
Tong Ren Tang Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access